Cargando...
Hemagglutinin-esterase cannot be considered as a candidate for designing drug against COVID-19
We read with interest the article by Patel et al. on the identification of potential inhibitors of coronavirus hemagglutinin-esterase. The authors considered hemagglutinin-esterase as a glycoprotein of SARS-CoV-2 and selected hemagglutinin-esterase as a target to identify potential inhibitors using...
Gardado en:
| Publicado en: | Mol Divers |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Springer International Publishing
2021
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8267763/ https://ncbi.nlm.nih.gov/pubmed/34241772 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11030-021-10272-w |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|